Inimmune To Present On Their Next Generation Adjuvants At World Vaccine Congress in Amsterdam
Missoula, MT — October 1st, 2025 — Inimmune, a biotechnology company pioneering novel vaccine adjuvants, immunotherapies, and delivery systems, announced today that its leadership team will deliver multiple presentations at the World Vaccine Congress (WVC) in Amsterdam, Netherlands, October 13–16, 2025. David Burkhart, Ph.D., CEO of Inimmune, will speak at the Vaccine Delivery Workshop on […]
